Injection for treating thrombus

A technology of injection and Danshen injection, which is applied in the direction of blood diseases, extracellular fluid diseases, medical preparations containing active ingredients, etc., can solve the problems of rapid onset, fierce onset, and slow curative effect of thrombosis diseases, and achieve economic relief. Burden, no toxic side effects, reasonable pH effect

Inactive Publication Date: 2009-04-08
山西长安血液血管病研究所
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the curative effect of traditional Chinese medicine treatment is generally slow, and the drug dosage is large, and the bioavailability is low.
Due to ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] Taking one injection as the dosage unit, each injection for the treatment of thrombus contains:

[0023] Salvia Injection 2mL

[0024] Chymotrypsin 1mg

[0025] Staphylokinase 100,000 IU

[0026] Add 5 mL of 0.9% normal saline.

[0027] The above medicines are mixed and sealed, strictly sterilized, stored at 0-10°C, and the shelf life is 1.5 years.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an injection liquid for the treatment of thrombosis, which consists of radix salviae miltiorrhizae injection, chymotrypsin, and staphylokinase, wherein each 5 milliliters of the injection liquid contains 1.8 to 2.5 milliliters of the radix salviae miltiorrhizae injection, 0.8 to 1.2 milligrams of the chymotrypsin, and 80,000 to 150, 000 IU of the staphylokinase. The injection liquid is mainly used for the treatments of thrombosis and vascular occlusion of heart, brain and every part of a whole body, and the main adaptation diseases are cardio-cerebral ischemia, myocardial infarction, cerebral infarction, pulmonary infarction, venous thrombosis, arterial thrombosis, and femoral head necrosis. The clinical efficacy of the injection liquid is significant, the total effective rate of treatment reaches 89 percent, and the cure rate is 76.5 percent.

Description

technical field [0001] The invention belongs to the field of medicine preparation, and in particular relates to an injection preparation for treating thrombus. The injection preparation of the present invention is prepared from the medicine of the national medicine Zhunzi brand. Background technique [0002] Thrombosis is one of the diseases that seriously endanger human health, especially cerebral thrombosis is difficult to cure clinically, and it is very easy to relapse, and most patients have sequelae. Therefore antithrombotic and thrombus-dissolving medicines are the focus of research by medical scientists from all over the world. [0003] At present, there are various kinds of antithrombotic drugs clinically and on the market, including oral drugs and injections, such as Xinnaokang, which is produced by more than a dozen manufacturers. In the early clinical stage, streptokinase and urokinase were used as the main means of dissolving thrombus, but the initial dose of s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/48A61P7/02A61K36/537
Inventor 孟平安孟晓波
Owner 山西长安血液血管病研究所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap